DK0773030T3 - Fremgangsmåde til oprensning af nekrotoksin produceret af Bordetella - Google Patents

Fremgangsmåde til oprensning af nekrotoksin produceret af Bordetella

Info

Publication number
DK0773030T3
DK0773030T3 DK95921113T DK95921113T DK0773030T3 DK 0773030 T3 DK0773030 T3 DK 0773030T3 DK 95921113 T DK95921113 T DK 95921113T DK 95921113 T DK95921113 T DK 95921113T DK 0773030 T3 DK0773030 T3 DK 0773030T3
Authority
DK
Denmark
Prior art keywords
toxoid
dermonecrotic toxin
produced
bordetella
dermonecrotic
Prior art date
Application number
DK95921113T
Other languages
English (en)
Inventor
Toru Kawai
Toshihiro Ushijima
Kozo Takase
Hideo Fujikawa
Original Assignee
Chemo Sero Therapeut Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeut Res Inst filed Critical Chemo Sero Therapeut Res Inst
Application granted granted Critical
Publication of DK0773030T3 publication Critical patent/DK0773030T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Epoxy Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK95921113T 1994-06-10 1995-06-07 Fremgangsmåde til oprensning af nekrotoksin produceret af Bordetella DK0773030T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP15283494 1994-06-10
PCT/JP1995/001125 WO1995034322A1 (en) 1994-06-10 1995-06-07 Method of purifying necrotoxin produced by bordetella and toxoid

Publications (1)

Publication Number Publication Date
DK0773030T3 true DK0773030T3 (da) 2003-12-22

Family

ID=15549157

Family Applications (2)

Application Number Title Priority Date Filing Date
DK95921113T DK0773030T3 (da) 1994-06-10 1995-06-07 Fremgangsmåde til oprensning af nekrotoksin produceret af Bordetella
DK02028045T DK1297845T3 (da) 1994-06-10 1995-06-07 Kombinationsvaccine omfattende toxoid af dermonekrotisk toxin produceret af Bordetella bronchiseptica

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK02028045T DK1297845T3 (da) 1994-06-10 1995-06-07 Kombinationsvaccine omfattende toxoid af dermonekrotisk toxin produceret af Bordetella bronchiseptica

Country Status (10)

Country Link
US (1) US6124432A (da)
EP (2) EP1297845B1 (da)
JP (2) JP3884066B2 (da)
CN (2) CN1279978C (da)
AT (2) ATE248603T1 (da)
CA (1) CA2192165A1 (da)
DE (2) DE69531690T2 (da)
DK (2) DK0773030T3 (da)
ES (2) ES2206507T3 (da)
WO (1) WO1995034322A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU769539B2 (en) 1999-01-29 2004-01-29 Zoetis Services Llc Adjuvants for use in vaccines
US7521059B2 (en) * 2004-06-14 2009-04-21 Fenwick Bradley W Kennel cough vaccine
CN103153337A (zh) 2010-09-28 2013-06-12 共立制药股份有限公司 黏膜佐剂组合物
IT201600076743A1 (it) * 2016-07-21 2018-01-21 St Superiore Di Sanita Nuovo uso del cnf1
CN107338208B (zh) * 2017-08-17 2020-07-28 天康生物股份有限公司 一种猪萎缩性鼻炎d型产毒多杀巴斯德氏菌疫苗株及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6176422A (ja) * 1984-09-22 1986-04-18 Chemo Sero Therapeut Res Inst 百日ぜきコンポ−ネントワクチンおよび百日ぜき・ジフテリア・破傷風混合ワクチンの製造方法
DE69131525T2 (de) * 1990-06-13 1999-11-25 Pfizer Inc., New York Pasteurella multocida toxoid enthaltende impfstoffe

Also Published As

Publication number Publication date
US6124432A (en) 2000-09-26
JP2006342175A (ja) 2006-12-21
DE69535964D1 (de) 2009-07-16
DE69531690T2 (de) 2004-07-08
CN1130225C (zh) 2003-12-10
ES2326793T3 (es) 2009-10-20
CN1279978C (zh) 2006-10-18
JP4340672B2 (ja) 2009-10-07
DK1297845T3 (da) 2009-07-13
EP0773030A1 (en) 1997-05-14
JP3884066B2 (ja) 2007-02-21
WO1995034322A1 (en) 1995-12-21
CN1154655A (zh) 1997-07-16
EP0773030B8 (en) 2004-01-14
CA2192165A1 (en) 1995-12-21
EP0773030B1 (en) 2003-09-03
ATE248603T1 (de) 2003-09-15
ES2206507T3 (es) 2004-05-16
DE69531690D1 (de) 2003-10-09
EP1297845A2 (en) 2003-04-02
EP1297845A3 (en) 2003-04-16
EP1297845B1 (en) 2009-06-03
EP0773030A4 (en) 1997-12-10
CN1494922A (zh) 2004-05-12
ATE432712T1 (de) 2009-06-15

Similar Documents

Publication Publication Date Title
ATE249244T1 (de) Aktivierte verbindungen und verfahren zur herstellung und reiningung
ATE44238T1 (de) Vakzine fuer gramnegative bakterien und verfahren zur herstellung derselben.
NZ215557A (en) Purification of immunoglobulin g using liquid chromatography or solid phase extraction
ATE69310T1 (de) Verfahren zur herstellung eines materials zur affinitaetschromatographie.
ATE74137T1 (de) Verfahren zur reinigung von toxinconjugaten unter verwendung von hydrophober chromatographie.
DE69407272D1 (de) Verfahren zum reinigen von 20 cs)-camptothecin
DK0773030T3 (da) Fremgangsmåde til oprensning af nekrotoksin produceret af Bordetella
EP0385118A3 (en) Use of compounds containing or binding sialic acid to neutralize bacterial toxins
DK0437687T3 (da) Fremgangsmåde til rensning af et 69.000 dalton-antigenisk protein fra Bordetella tertussis
ATE2090T1 (de) Verfahren zur herstellung eines plasminogenaktivators, so erhaltener aktivator und ihn enthaltendes arzneimittel.
EP0668316A3 (en) Polyvinyl chloride resin composition and process for its production.
FI952144A0 (fi) Ei tyypittävissä olevan Haemphilus influenzaen puhdistettu P5 proteiini rokotteena ei tyypittävissä olevalle Haemophilus influenzae -kannalle
PT816377E (pt) Peptideos que se ligam a protrombina e a trombina
PT95789A (pt) Metodo para isolamento e purificacao de factores antigenicos da bordetella pertussis
FR2422699A1 (fr) Procede de preparation d'un materiau solide poreux revetu de cellulose ou de cellulose modifiee
EP0090660A3 (en) Neisseria gonorrhoeae vaccine
GB2007244A (en) Purifying Polyribosyl Ribitol Phosphate (PRP) and Vaccines containing Immunologically Active PRP
DE3875296D1 (de) Verfahren zur selektiven n-acylierung von amino-hydroxamsaeurederivaten und darin verwendete ausgangsstoffe.
ATE76082T1 (de) Reinigungsmethode fuer antikoerper.
SE8403929L (sv) Rekombinant-dna-molekyl, transformerade mikroorganismer och forfarande for framstellning av penicillin v-amidas
DK0408734T3 (da) Fremgangsmåde til rensning af streptokinaser
JPS57140726A (en) Purification of physiologically active substance having carcinostatic action
DK163582A (da) Fremgangsmaade til rensning af et fysiologisk aktivt stof med antitumorvirkning
AU7158087A (en) Affinity chromatography method for the separation and purification of protein antigens of the bacteria of the bordetella genus
FR2104732A1 (en) Asparaginase purification using asparagine in - hibitors coupled to carbohydrate matrix